Millions of consumers may be drooling over the latest versions of their favorite smartphones and tablets, amazed by the sharp displays, powerful cameras, and panoply of applications. But deep inside Google’s experimental hardware unit, where people work on crazy-sounding ideas like driverless cars and balloon-lofted wireless networks, all of that electronics-store stuff is starting to … Continue reading “Google X Display Head: Smartphones, Tablets, Apps are “Mind-Numbing””
Category: Boston
Steve Case on Lessons for Entrepreneurs and HS Seniors
It was a totally packed house last night, with more than 200 people crammed into the cool new theater and networking space at the Cambridge Innovation Center’s Venture Café here in Cambridge, MA. The person of interest for the invitation-only crowd: AOL founder-turned-venture capitalist Steve Case. Case, of course, is one of the best-known entrepreneurs … Continue reading “Steve Case on Lessons for Entrepreneurs and HS Seniors”
Venture Goes Mobile as 3rd Quarter Deal Activity Hits 12-Year High
Venture deal activity hit a 12-year high during the third quarter, and big VC investments in Uber, Kymeta, and Flipboard helped push venture funding for U.S. mobile startups over $1 billion for the first time, according to a report today from CB Insights. The New York financial data firm says the 857 venture deals nationwide … Continue reading “Venture Goes Mobile as 3rd Quarter Deal Activity Hits 12-Year High”
KinematIQ Lands $143,600 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=39381ce4-195d-4897-9e19-38a70148d8cb Date 10/10/2013 Company Name KinematIQ Mailing Address 55A Brewster Avenue Winthrop, MA 02152 Company Description Everything in this world moves! KinematIQ helps people track those movements with a small, cheap and simple device. But we don’t stop there – a back end software platform will make sense of this data for … Continue reading “KinematIQ Lands $143,600 New Financing”
Achvr Secures $1,250,000 Seed Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2f8bc96c-e439-45dc-9a61-9052f6aeb417 Date 10/10/2013 Company Name Achvr Mailing Address 210 South St. 2nd Floor Boston, MA 02111 Company Description Here at Achvr, we’re all about doing. We provide a unique way for you to discover, share, and track all of the amazing things you want to do, and keep score of all the … Continue reading “Achvr Secures $1,250,000 Seed Funding Round”
CTI Towers Receives $30,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=41309fe7-a411-436d-be26-c0f53785882d Date 10/10/2013 Company Name CTI Towers Mailing Address 38 Pond St Franklin, MA 02038 Company Description CTI Towers, Inc., was formed in 2011 to own, operate, manage, and maintain wireless towers throughout the United States. Website http://www.ctitowers.com Transaction Type Debt Transaction Amount $30,000,000 Transaction Round Undisclosed Proceeds Purposes The debt facility … Continue reading “CTI Towers Receives $30,000,000 New Funding Round”
Myomo Continues Comeback, Adds $2M to Boost Robotic Arm Brace
Myomo, a medical-device startup whose robotic braces act like “power steering for your arm,” has buttoned up a venture round as it continues an intriguing corporate comeback story. The newest round of financing—$2 million from individual angels and venture firm Mountain Group Capital—is the final piece of a $7 million investment the company started collecting … Continue reading “Myomo Continues Comeback, Adds $2M to Boost Robotic Arm Brace”
Ariad Halts Leukemia Drug Trials Due to Safety Concerns, Shares Plummet
Ariad Pharmaceuticals’ (NASDAQ: [[ticker:ARIA]]) plans to go head to head with imatinib (Gleevec) just went up in smoke. In a big setback for the Cambridge, MA-based biotech, Ariad said Wednesday that it has halted its ongoing clinical trials of ponatinib (Iclusig), including a key study testing the drug as a frontline treatment for patients with … Continue reading “Ariad Halts Leukemia Drug Trials Due to Safety Concerns, Shares Plummet”
Startups Thrive on Competition, Not Non-Competes
It’s time to stop pretending that people are DVDs. It’s time to get rid of employee non-competes. A DVD is a simple piece of plastic that only has value because someone (often a company) filled it with useful information, like a movie or a computer program. A blank DVD isn’t very valuable, but a DVD … Continue reading “Startups Thrive on Competition, Not Non-Competes”
Steve Blank’s UCSF Class Tests “Evidence-Based Entrepreneurship”
Conventional wisdom says the techniques that help today’s technology startups get to market fast—or, just as likely, fail fast, freeing the founders to start over—don’t work in the life sciences. Rapid product iteration based on agile software development methods; continuous business-model adjustments using customer feedback; cloud outsourcing to increase capital efficiency—all these strategies are seen … Continue reading “Steve Blank’s UCSF Class Tests “Evidence-Based Entrepreneurship””
Sample6 Receives $11,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f127f444-f480-4ec1-97d7-681a7b834b58 Date 10/9/2013 Company Name Sample6 Mailing Address 27 Drydock Avenue 2nd Floor Boston, MA 02210 Company Description Sample6 Technologies is a dynamic startup company at the intersection of breakthroughs in synthetic biology, sensors, and data modeling and visualization. The company’s mission is to improve the health and safety of global consumers … Continue reading “Sample6 Receives $11,000,000 Series B Financing Round”
HealthEdge Software Garners $17,500,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=473de97f-6097-4c67-ab7b-2f426534cf16 Date 10/9/2013 Company Name HealthEdge Software Mailing Address 3 Van de Graaff Drive Burlington, MA 01803 Company Description HealthEdge provides health plans, TPAs, PPOs, and insurers of all sizes with unique software applications to position them for success. Website http://www.healthedge.com Transaction Type Debt Transaction Amount $17,500,000 Transaction Round Undisclosed Proceeds Purposes … Continue reading “HealthEdge Software Garners $17,500,000 New Round”
Swirl Finds $8M from Hearst for Bluetooth Beacons and Mobile Ads
With millions of shoppers carrying around ever more powerful smartphones, it’s probably inevitable that savvy retailers will start pumping coupons, deals, and other enticements directly to the screens in our pockets and purses. But truly intelligent in-store digital ads, especially ones tied to your location in the aisles, aren’t quite here yet—even though plenty of … Continue reading “Swirl Finds $8M from Hearst for Bluetooth Beacons and Mobile Ads”
Science: The Missing Ingredient in the GMO Food Labeling Debate
Residents of Washington State are currently being buried in an avalanche of ads regarding a citizen’s initiative that would require the labeling of genetically engineered foods sold in grocery stores. Estimates for the percentage of items that contain genetically engineered ingredients in a grocery store range from 60 percent to 70 percent (most of those … Continue reading “Science: The Missing Ingredient in the GMO Food Labeling Debate”
Swirl Networks Lands $8,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c702e208-f73c-42a4-a70b-46e684c2b2c6 Date 10/8/2013 Company Name Swirl Networks Mailing Address 420 Boylston Street 3rd Floor Boston, MA 02116 Company Description We build products that connect people around their passions in a simple, beautiful and useful way. Website http://www.swirl.com Transaction Type Venture Equity Transaction Amount $8,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were … Continue reading “Swirl Networks Lands $8,000,000 New Financing”
Nextly Garners $599,993 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed320778-c6b6-44ba-b399-77022010f881 Date 10/8/2013 Company Name Nextly Mailing Address 727 Massachusetts Avenue Cambridge, MA 02139 Company Description Nextly is Smarter, Faster and Better browsing. Website http://www.nextly.com Transaction Type Venture Equity Transaction Amount $599,993 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation. M&A Terms Venture Investor … Continue reading “Nextly Garners $599,993 New Funding”
Myomo Obtains $3,325,083 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d5432f39-1718-41ae-b63e-d807bd07c765 Date 10/8/2013 Company Name Myomo Mailing Address One Broadway 14th Floor Cambridge, MA 02142 Company Description Myomo is pioneering NeuroRobotics, a new category of non-invasive medical device technology to help people relearn how to move severely weak or partially paralyzed limbs. Originally an acronym for Muscle-Motion, Myomo (pronounced MY-O-MO) was re-defined … Continue reading “Myomo Obtains $3,325,083 New Funding”
Boston’s Life Science Disruptors: The Photos
They came. We saw. They disrupted. On Friday, I recapped our latest biotech event, “Boston’s Life Science Disruptors,” with some key takeaways from the stars of the show: Genocea Biosciences, Moderna Therapeutics, and Bluebird Bio (NASDAQ: [[ticker:BLUE]]). Today, as promised, I’ve circled back with a slideshow look at the festivities, including shots of the speakers, … Continue reading “Boston’s Life Science Disruptors: The Photos”
Karyopharm Enters IPO Queue, Plots up to $80M Raise For Cancer Drug
Karyopharm Therapeutics raised close to $50 million just a few months ago to continue developing its lead cancer drug. Now it’s turning to Wall Street to help with the effort. Karyopharm filed a Form S-1 with the SEC late Friday outlining plans to raise up to $80 million through an IPO, hoping to capitalize on … Continue reading “Karyopharm Enters IPO Queue, Plots up to $80M Raise For Cancer Drug”
How We Overturned the Retroactive Tax on Startup Founders
The call came at 1:15 pm this past Friday, as I was driving home from a client meeting. “Mr. Overstreet?” questioned the voice on the other end of the line. “I’m calling from Governor Brown’s office. We wanted you to be the first to know that the Governor signed your bill into law.” And just … Continue reading “How We Overturned the Retroactive Tax on Startup Founders”
Harvard’s Verdine Blazing Trail for Scientific Entrepreneurs
If you’re a tenured biomedical researcher at a university today, and you have a big idea for what could be a new drug or diagnostic test, you can do a couple things. Hand it off to someone else at a startup, keep your day job, dabble as an advisor for a couple hours a week … Continue reading “Harvard’s Verdine Blazing Trail for Scientific Entrepreneurs”
9 Takeaways from Boston’s Life Science Disruptors
Building a biotech is (really) hard. But if you’re doing to do it, be yourself. Don’t take yourself too seriously. Wear sneakers if you feel like it. Near-death experiences happen to everyone along the way—embrace them and learn. And if your initial hunch is that the company’s founding idea is insane, it’s probably worth pursuing. … Continue reading “9 Takeaways from Boston’s Life Science Disruptors”
Twitter’s Purchase of Crashlytics & Bluefin Labs: Prices Confirmed
In Twitter’s IPO filing, one of the interesting nuggets has to do with the acquisition prices of Boston-area startups Bluefin Labs and Crashlytics. Or rather, what Twitter is saying about those prices (and what it’s not saying). I have confirmed with two sources who have knowledge of the deals that the values I originally reported … Continue reading “Twitter’s Purchase of Crashlytics & Bluefin Labs: Prices Confirmed”
Four Reasons to Encourage Employees to Take Smart Risks
The economic downturn and subsequent market volatility have made risk into a four-letter word. Employees, in particular, are growing increasingly risk-averse, afraid of layoffs and the prospect of extended unemployment. Many of them opt to be cautious rather than brave, to stick to the status quo, and to keep their heads down, rather than challenge … Continue reading “Four Reasons to Encourage Employees to Take Smart Risks”
The Winds of the Future: 5 Ways San Francisco Stays Innovative
In 1920, the San Francisco Bulletin, which was then one of the city’s major newspapers, published a poem by George Sterling, a figure in the city’s Bohemian arts circles. It read in part: The winds of the Future wait At the iron walls of her Gate, And the western ocean breaks in thunder, And the … Continue reading “The Winds of the Future: 5 Ways San Francisco Stays Innovative”
East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More
Two pharmaceutical giants shook up the Tri-State area this week, while one of the Boston area’s most radical biotechs got another big vote of confidence. Those details and much more below: —Cambridge, MA-based Moderna Therapeutics turned heads in the biotech world when it got a $240 million up front check from AstraZeneca (NYSE: [[ticker:AZN]]) earlier … Continue reading “East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More”
eTouches Receives $5,500,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8555f9e9-74e3-4b11-b290-859fd359c292 Date 10/4/2013 Company Name eTouches Mailing Address 13 Marshall Street Norwalk, CT 06854 Company Description eTouches is a web-based software as a service (SaaS) provider to the $3.0 billion global, meeting and event technology marketplace. Website http://www.etouches.com Transaction Type Venture Equity Transaction Amount $5,500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes … Continue reading “eTouches Receives $5,500,000 New Financing”
Join Xconomy for Profiles in Biotech Perseverance in SF Dec. 9
Drugs don’t just roll out of anybody’s lab by next Tuesday, and then keep popping out on some exponential curve. The biotech industry depends on investors who are willing to speculate on hot ideas in science, and wait years to see a payoff that may never come. That notion, which has been with the industry … Continue reading “Join Xconomy for Profiles in Biotech Perseverance in SF Dec. 9”
Boston Roundup: Pursway, Logentries, Paydiant, Healthrageous
Updated 4 pm Some fundraising, customer announcement, and shutdown news from Boston-area startups in several different sectors: —Pursway, a marketing software company, has raised $7.2 million in new investment to expand its product and sales teams. The company moved from Israel to the Boston area in 2010, raising a $6 million Series A investment from … Continue reading “Boston Roundup: Pursway, Logentries, Paydiant, Healthrageous”
The Human Genome Project Wasn’t Overhyped. The Payoff Just Took Time
[This post was co-authored by Sean Harper, Amgen’s executive vice president of R&D.] People in the tech industry often like to say that we overestimate the short-term impact of new technology and underestimate the longer-term value. The human genome project is a superb example of this truism. Overpromise was indeed rampant during the interval around … Continue reading “The Human Genome Project Wasn’t Overhyped. The Payoff Just Took Time”
Ping4 Receives $1,850,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3accf85e-490b-4abf-ac4b-1a3d73620dc8 Date 10/3/2013 Company Name Ping4 Mailing Address 20 Cotton Road Nashua, NH 03063 Company Description Ping4 is the revolutionary new mobile messaging platform that pushes real-time alerts and rich content to your smartphone based on your location, preferences, or proximity to your favorite stores. Best of all, it’s free. Website http://www.ping4.com … Continue reading “Ping4 Receives $1,850,000 New Financing”
Collegium Pharmaceutical Lands $4,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=523eba9e-a0f1-4819-a7f6-723fc39f3188 Date 10/3/2013 Company Name Collegium Pharmaceutical Mailing Address 780 Dedham Street Canton, MA 02021 Company Description Collegium Pharmaceutical is dedicated to the development of proprietary, late stage pharmaceutical products that add market value and clinical benefit to existing drugs. We apply customized pharmaceutical formulations and intellectual property (IP) strategies to drugs … Continue reading “Collegium Pharmaceutical Lands $4,000,000 New Financing Round”
Calorics Receives $10,231,974 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=92c25895-6780-4b42-b3ff-e2fee774f8d2 Date 10/3/2013 Company Name Calorics Mailing Address 1000 Winter Street Waltham, MA 02451 Company Description The company uses a proprietary, yeast-based platform to decipher the biology of caloric restriction, nutrient sensing and related diseases of aging and to discover novel drugs for these conditions. Website Undisclosed Transaction Type Venture Equity Transaction … Continue reading “Calorics Receives $10,231,974 New Financing”
Apperian Founder Goldman on Joining Great Hill to Do Mobile Rollups
Any time a founder leaves a startup, it makes news. That’s why we were interested to hear that Apperian founder Chuck Goldman has joined Great Hill Partners as an executive-in-residence (see news brief here). Goldman, a former Apple executive who helped launch the original iPhone, started Boston-based Apperian in 2009 and led the company from … Continue reading “Apperian Founder Goldman on Joining Great Hill to Do Mobile Rollups”
Moderna Snags $25M DARPA Grant to Fight Pandemics With mRNA Drugs
One of the wilder ideas in biotechnology just got a vote of confidence from the people who gave the world the Internet. Cambridge, MA-based Moderna Therapeutics is announcing later today it has snagged a grant worth as much as $24.6 million over the next five years from the Defense Advanced Research Projects Agency (DARPA). The … Continue reading “Moderna Snags $25M DARPA Grant to Fight Pandemics With mRNA Drugs”
Seeing Beyond the IPO Window Dressing
In his Life Sci VC blog, Bruce Booth recently wrote “Biotech is back with a vengeance in this IPO window.” It’s an accurate snapshot of the market, but the good times he describes accrue to money and sweat equity already long in the ground. In a business with a 10- to 15-year product development cycle, … Continue reading “Seeing Beyond the IPO Window Dressing”
Quantopian Obtains $6,700,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aa1c17f7-7d5b-4e40-95a2-655ea16bcf3e Date 10/2/2013 Company Name Quantopian Mailing Address 77 Summer St. 3rd Floor Boston, MA 02110 Company Description Quantopian is a platform for you to build, test, and execute trading algorithms. Website http://www.quantopian.com Transaction Type Venture Equity Transaction Amount $6,700,000 Transaction Round Series A Proceeds Purposes The new funding will be used … Continue reading “Quantopian Obtains $6,700,000 Series A Round”
Intelligent Clearing Network Garners $1,100,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=752c61c7-9a6a-43fd-a589-9559ca1898e6 Date 10/2/2013 Company Name Intelligent Clearing Network Mailing Address 31 Lakeview Ave. New Canaan, CT 06840 Company Description ICN was founded by a team of software engineers and business managers who realized that the efficiency and fraud related to coupons was well documented and persistent. While digital couponing is by far … Continue reading “Intelligent Clearing Network Garners $1,100,000 New Financing Round”
Viewfinity Receives $1,450,003 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aec19543-ff6a-40ea-9b63-c84f9c25af86 Date 10/2/2013 Company Name Viewfinity Mailing Address 400 Totten Pond Road Waltham, MA 02451 Company Description Viewfinity offers uncomplicated systems management solutions to manage, support and control desktops, laptops and Windows servers, regardless of worker location, via SaaS-enabled software. In four easy steps, and in less than 10 minutes, IT departments … Continue reading “Viewfinity Receives $1,450,003 New Financing”
Pursway Obtains $7,200,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=72b35101-cc9c-4124-9175-e4065ad14543 Date 10/2/2013 Company Name Pursway Mailing Address 303 Wyman Street Waltham, MA 02451 Company Description Pursway (previously known as Datanetis) empowers consumer-facing organizations to close this gap between how they market and how people buy. Website http://www.pursway.com Transaction Type Venture Equity Transaction Amount $7,200,000 Transaction Round Undisclosed Proceeds Purposes The new … Continue reading “Pursway Obtains $7,200,000 New Financing”
MX Orthopedics Receives $1,420,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=147a3051-baff-4c91-9130-e5000fae059e Date 10/2/2013 Company Name MX Orthopedics Mailing Address 12 Suburban Park Drive Billerica, MA 01821 Company Description Mx Orthopedics has created a next generation hip implant device that it says minimizes future movement of the device. Website http://www.mxortho.com Transaction Type Venture Equity Transaction Amount $1,420,000 Transaction Round Undisclosed Proceeds Purposes Proceeds … Continue reading “MX Orthopedics Receives $1,420,000 New Financing Round”
The Memo That Spawned Microsoft Research—Analysis and Download
Microsoft Research, the central research arm of that tech giant of the northwest, was founded in September 1991. This is the prehistory. With the recent stepping down of Rick Rashid—the head of the organization since its inception, who took a new job at Microsoft in July—I have decided to post the memo that gave birth … Continue reading “The Memo That Spawned Microsoft Research—Analysis and Download”
The Memo That Spawned Microsoft Research—and Its Lessons for Today
How many great corporate organizations were created with the words, “Once upon a time?” Not many, I’ll wager. Yet that is exactly how Microsoft Research, one of the world’s biggest and most prestigious corporate research institutions, came to life back in 1991. “Once upon a time,” former Microsoft CTO Nathan Myhrvold wrote to Bill Gates … Continue reading “The Memo That Spawned Microsoft Research—and Its Lessons for Today”
The End of Personal Computers
Lately, we’ve been hearing a lot about the idea that we are witnessing “the end of personal computers,” the “post-PC era,” or, as Microsoft would have it, the “PC-plus era.” The difference in terminology is telling, revealing the intense commercial competition and staggering financial stakes that underlie this transition. For those who have been in … Continue reading “The End of Personal Computers”
A Wild September for Wireless: Putting it in Context
A wild and wacky wireless September it was. In one of the most frenzied months in the history of nearly any tech sector, we saw the following developments dominate the headlines: Verizon bought out Vodafone’s stake in Verizon Wireless for $130 billion. In a week, this financing went from “can they do it” to being … Continue reading “A Wild September for Wireless: Putting it in Context”
ARGO Medical Technologies Lands New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=22ab54bd-3ca3-4e9f-94e1-43e1281659c0 Date 10/1/2013 Company Name ARGO Medical Technologies Mailing Address 33 Locke Drive 2nd Floor Marlborough, MA 01752 Company Description Argo Medical Technologies Ltd. develops, manufactures, and markets walk restoration devices for people with lower limb disabilities. It offers ReWalk, an ambulation and rehabilitation alternative mobility solution to the wheelchair for individuals … Continue reading “ARGO Medical Technologies Lands New Financing Round”
BiddingForGood Obtains $2,100,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6eb564f7-71d4-400a-a1ac-447a7e7d0fcd Date 10/1/2013 Company Name BiddingForGood Mailing Address 100 CambridgePark Drive Cambridge, MA 02140 Company Description BiddingForGood is a charitable e-commerce company that connects fundraisers, cause-conscious shoppers, and socially responsible businesses. We provide a unique online auction platform, where nonprofits and schools, consumers and businesses converge to create dynamic and exciting fundraising … Continue reading “BiddingForGood Obtains $2,100,000 New Round”
Cydan Secures $10,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=282a660c-bacc-4858-87b2-9d933ca10b66 Date 10/1/2013 Company Name Cydan Mailing Address 300 Technology Square 8th Floor Cambridge, MA 02139 Company Description Cydan is an orphan drug accelerator that identifies and de-risks compounds with therapeutic and commercial potential. Our rigorous process generates data to support a development path and new company formation. Website http://www.cydanco.com Transaction Type … Continue reading “Cydan Secures $10,000,000 New Funding”
Leaf Adds $20M as Payments Sector Heats Up
Deals are starting to fly in the battle over small-business payment processing. Cambridge, MA-based Leaf, a startup that sells point-of-sale systems built around Android-based tablets, says it has raised a $20 million investment round. The investor is Heartland Payment Systems, a national merchant payments provider. The investment is significant for Leaf, which had previously raised … Continue reading “Leaf Adds $20M as Payments Sector Heats Up”
Xconomy Boston’s Top 10 Stories from Q3 2013: Editor’s Picks
Herpes, PowerBars, and IPOs. Apple, Amazon, and acoustics. What more can you ask? Well, we’ve seen them all around town in the past three months. It’s the end of the third quarter, and with that, I’d like to highlight my 10 favorite Xconomy Boston stories from the period. They are a mix of company profiles, … Continue reading “Xconomy Boston’s Top 10 Stories from Q3 2013: Editor’s Picks”